FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366526475> ?p ?o ?g. }

• W4366526475 endingPage "9" @default.
• W4366526475 startingPage "1" @default.
• W4366526475 abstract "In Egypt, bladder cancer (BC) represents about 8.7% of cancers in both sexes. In Egyptian men, it accounts for over 30% of all cancers, which makes it the second most frequent cancer. The standard curative treatment for patients with muscle-invasive bladder cancer (MIBC) has been radical cystectomy (RC) with urinary diversion and pelvic lymphadenectomy. Concomitant chemoradiation therapy (CCRT) in MIBC appears to produce results that are comparable to those of RC.Between January 2018 and March 2021, 34 BC- diagnosed patients, who refused RC, were enrolled. They received transurethral resection of the bladder tumour (TURBT) followed by 3 cycles of neoadjuvant chemotherapy (NACT) with gemcitabine, cisplatin, and CCRT. Concomitant chemoradiation therapy with cisplatin, as a chemosensitizer, was administered to patients who experienced a complete response (CR) and a partial response (PR) ≥ 50%.Following NACT, CCRT was given to 27 patients (79.45%) who had either a PR > 50% or CR. Seven patients (20.5%) showed PR below 50%, stable disease, or progressive disease; 4 of them underwent RC followed by postoperative radiation. The average follow-up period was 46 months (range: 6-52 months). Twenty-three patients (67.6%) were still alive at the last check-up. Disease-free survival and 3-year overall survival were 70.8% and 65.1%, respectively.Bladder preservation provides survival rates comparable to those of MIBC patients, but with a higher quality of life. The findings show good survival rates without metastasis; nevertheless, more multicentre trials with larger sample sizes and longer follow-up periods are required to confirm these findings." @default.
• W4366526475 created "2023-04-22" @default.
• W4366526475 creator A5000370425 @default.
• W4366526475 creator A5005461132 @default.
• W4366526475 creator A5033177641 @default.
• W4366526475 creator A5043208771 @default.
• W4366526475 creator A5045440642 @default.
• W4366526475 creator A5059420314 @default.
• W4366526475 creator A5075421947 @default.
• W4366526475 creator A5086263572 @default.
• W4366526475 creator A5090490127 @default.
• W4366526475 date "2023-01-01" @default.
• W4366526475 modified "2023-10-01" @default.
• W4366526475 title "Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer" @default.
• W4366526475 cites W2002256882 @default.
• W4366526475 cites W2011729580 @default.
• W4366526475 cites W2019607817 @default.
• W4366526475 cites W2036602244 @default.
• W4366526475 cites W2036777171 @default.
• W4366526475 cites W2043945205 @default.
• W4366526475 cites W2044912897 @default.
• W4366526475 cites W2049473720 @default.
• W4366526475 cites W2057750067 @default.
• W4366526475 cites W2071306483 @default.
• W4366526475 cites W2090241022 @default.
• W4366526475 cites W2113156769 @default.
• W4366526475 cites W2130834017 @default.
• W4366526475 cites W2139248078 @default.
• W4366526475 cites W2140310677 @default.
• W4366526475 cites W2157020021 @default.
• W4366526475 cites W2160797158 @default.
• W4366526475 cites W2166453367 @default.
• W4366526475 cites W2168846224 @default.
• W4366526475 cites W2265951019 @default.
• W4366526475 cites W2332342311 @default.
• W4366526475 cites W2396961717 @default.
• W4366526475 cites W2507862526 @default.
• W4366526475 cites W2571353830 @default.
• W4366526475 cites W2597498496 @default.
• W4366526475 cites W2605794623 @default.
• W4366526475 cites W2606173101 @default.
• W4366526475 cites W2607756307 @default.
• W4366526475 cites W2750871166 @default.
• W4366526475 cites W2767805252 @default.
• W4366526475 cites W2781525129 @default.
• W4366526475 cites W2808411766 @default.
• W4366526475 cites W3010197652 @default.
• W4366526475 cites W3178101143 @default.
• W4366526475 cites W3214782373 @default.
• W4366526475 doi "https://doi.org/10.5114/wo.2023.126754" @default.
• W4366526475 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37266340" @default.
• W4366526475 hasPublicationYear "2023" @default.
• W4366526475 type Work @default.
• W4366526475 citedByCount "0" @default.
• W4366526475 crossrefType "journal-article" @default.
• W4366526475 hasAuthorship W4366526475A5000370425 @default.
• W4366526475 hasAuthorship W4366526475A5005461132 @default.
• W4366526475 hasAuthorship W4366526475A5033177641 @default.
• W4366526475 hasAuthorship W4366526475A5043208771 @default.
• W4366526475 hasAuthorship W4366526475A5045440642 @default.
• W4366526475 hasAuthorship W4366526475A5059420314 @default.
• W4366526475 hasAuthorship W4366526475A5075421947 @default.
• W4366526475 hasAuthorship W4366526475A5086263572 @default.
• W4366526475 hasAuthorship W4366526475A5090490127 @default.
• W4366526475 hasBestOaLocation W43665264751 @default.
• W4366526475 hasConcept C121608353 @default.
• W4366526475 hasConcept C126322002 @default.
• W4366526475 hasConcept C126894567 @default.
• W4366526475 hasConcept C141071460 @default.
• W4366526475 hasConcept C143998085 @default.
• W4366526475 hasConcept C2775910329 @default.
• W4366526475 hasConcept C2776694085 @default.
• W4366526475 hasConcept C2777284795 @default.
• W4366526475 hasConcept C2778239845 @default.
• W4366526475 hasConcept C2779384505 @default.
• W4366526475 hasConcept C2780258809 @default.
• W4366526475 hasConcept C2780352672 @default.
• W4366526475 hasConcept C2780824555 @default.
• W4366526475 hasConcept C509974204 @default.
• W4366526475 hasConcept C71924100 @default.
• W4366526475 hasConceptScore W4366526475C121608353 @default.
• W4366526475 hasConceptScore W4366526475C126322002 @default.
• W4366526475 hasConceptScore W4366526475C126894567 @default.
• W4366526475 hasConceptScore W4366526475C141071460 @default.
• W4366526475 hasConceptScore W4366526475C143998085 @default.
• W4366526475 hasConceptScore W4366526475C2775910329 @default.
• W4366526475 hasConceptScore W4366526475C2776694085 @default.
• W4366526475 hasConceptScore W4366526475C2777284795 @default.
• W4366526475 hasConceptScore W4366526475C2778239845 @default.
• W4366526475 hasConceptScore W4366526475C2779384505 @default.
• W4366526475 hasConceptScore W4366526475C2780258809 @default.
• W4366526475 hasConceptScore W4366526475C2780352672 @default.
• W4366526475 hasConceptScore W4366526475C2780824555 @default.
• W4366526475 hasConceptScore W4366526475C509974204 @default.
• W4366526475 hasConceptScore W4366526475C71924100 @default.
• W4366526475 hasIssue "1" @default.
• W4366526475 hasLocation W43665264751 @default.
• W4366526475 hasLocation W43665264752 @default.

• next